Singapore-based speciality biopharmaceutical company Invida Group Private Limited has acquired the dermatology and baby care product brands of Delhi-based Shalaks Pharmaceuticals Pvt. Ltd. for Rs 100 crore. The transaction also includes acquisition of trademarks and technical know-how for the dermatology and baby care portfolio.
Invida Group is a three way venture between Quintiles, a pharmaceutical services organization, Singapore sovereign wealth fund Temasek Holdings and Zuellig Group,...Full story
